Edition:
United States

Applied DNA Sciences Inc (APDN.OQ)

APDN.OQ on NASDAQ Stock Exchange Capital Market

2.57USD
15 Dec 2017
Change (% chg)

$-0.11 (-4.10%)
Prev Close
$2.68
Open
$2.69
Day's High
$2.69
Day's Low
$2.53
Volume
20,897
Avg. Vol
17,463
52-wk High
$3.45
52-wk Low
$0.90

Latest Key Developments (Source: Significant Developments)

Applied DNA Q4 Loss Per Share $0.10
Friday, 15 Dec 2017 05:23pm EST 

Dec 15 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA ANNOUNCES SELECTED PRELIMINARY UNAUDITED FISCAL FOURTH QUARTER AND YEAR END RESULTS.Q4 LOSS PER SHARE $0.10.Q4 REVENUE FELL 30 PERCENT TO $1.1 MILLION.  Full Article

APPLIED DNA SECURES 1-YEAR CONTRACT EXTENSION WITH DEFENSE LOGISTICS AGENCY
Monday, 20 Nov 2017 05:30am EST 

Nov 20 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA SCIENCES INC - ‍DEFENSE LOGISTICS AGENCY (DLA) HAS AWARDED CO A ONE-YEAR EXTENSION OF ITS CURRENT CONTRACT THROUGH OCTOBER 13, 2018​.  Full Article

Double Medical Technology Inc sees FY 2017 net profit to up 20 pct to 40 pct
Friday, 27 Oct 2017 01:11am EDT 

Oct 27 (Reuters) - Double Medical Technology Inc <002901.SZ> ::Sees FY 2017 net profit to increase by 20 percent to 40 percent, or to be 263.2 million yuan to 307.1 million yuan.Says FY 2016 net profit was 219.3 million yuan.Says steady growth of main businesses as main reason for the forecast.  Full Article

Applied DNA signs Cooperative Research And Development Agreement with U.S. Army
Tuesday, 12 Sep 2017 05:30am EDT 

Sept 12 (Reuters) - Applied DNA Sciences Inc :Applied DNA signs Cooperative Research And Development Agreement with U.S. Army to study commercialization of rapid in-field DNA detection technology.Applied DNA Sciences - ‍project goal is to demonstrate system with co's taggants introduced into standard inks or varnishes or onto other surfaces.  Full Article

Applied DNA Q3 loss per share $0.10
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - Applied DNA Sciences Inc :Applied DNA reports fiscal third quarter 2017 financial results.Q3 loss per share $0.10.Q3 revenue rose 175 percent to $1.8 million.  Full Article

Applied DNA Sciences enters into subscription agreements for private placement of common stock
Wednesday, 28 Jun 2017 09:43am EDT 

June 28 (Reuters) - Applied DNA Sciences Inc ::Applied DNA Sciences says entered into subscription agreements for private placement of common stock with group of investors.Applied DNA Sciences says will issue and sell 1.0 million shares of common stock at a price of $1.76 per share.  Full Article

Wuhan Thalys Medical Technology unit signs service contract with Yichun People's Hospital
Monday, 26 Jun 2017 05:09am EDT 

June 26(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS> ::* Says its unit signed service contract with Yichun People's Hospital for reagent and concentralized distribution.  Full Article

Applied DNA wins 2-year, $1.5 mln competitive-bid development contract from the Office of the Secretary of Defense
Tuesday, 6 Jun 2017 05:30am EDT 

June 6 (Reuters) - Applied DNA Sciences Inc ::Applied DNA wins two-year, $1.5 million competitive development contract from the Office of the Secretary of Defense.Award, funded by Office of Secretary of Defense on behalf of Defense Logistics Agency runs from June 1, 2017 to May 31, 2019.  Full Article

Applied DNA Sciences reports Q2 loss per share $0.13
Thursday, 11 May 2017 04:05pm EDT 

May 11 (Reuters) - Applied DNA Sciences Inc :Applied DNA Sciences reports fiscal second quarter 2017 financial results.Q2 loss per share $0.13.Q2 revenue $905,000.Sees FY 2017 revenue about $500,000.  Full Article

Applied DNA Sciences signs 5-year supply agreement for bulk DNA manufacturing
Thursday, 20 Apr 2017 05:30am EDT 

April 20 (Reuters) - Applied DNA Sciences Inc :Applied DNA Sciences signs 5-year supply agreement for bulk DNA manufacturing.Applied DNA Sciences - Expect agreement to generate annual revenues of about $500,000 beginning in FY 2018 with a pro-rated amount expected in Q4 of 2017.  Full Article

BRIEF-Applied DNA Q4 Loss Per Share $0.10

* APPLIED DNA ANNOUNCES SELECTED PRELIMINARY UNAUDITED FISCAL FOURTH QUARTER AND YEAR END RESULTS